Skip to content
08 Jun

A Novel Imaging Biomarker for Retinal Neurodegeneration

Current Projects

The Phase 1 clinical trial of a novel diagnostic test in retinal neurodegeneration is to commence in mid-2014.
The technology will provide the first ever images of apoptosing cells in the human retina in real-time and a unique datsaet. To distinguish changes attributable to glaucoma as opposed to other diseases, an automated, cell counting algorithm with a pattern-recognition element needs to be developed, where focal and diffuse changes can be visualised depending on the localisation of labelled cells.